| Short Description : | Recombinant-Human FGF-19-C-His protein was developed in hek293 cells using the region Phe27-Lys216. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: | Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human FGF19 at 5 Mu g/mL (100 Mu L/well) can bind Recombinant Human FGFR4 with a linear range of 0.9-3.8 Mu g/mL. |
| Determination Method: | < 0.1 EU/Mu g of the protein by LAL method. |
| Gene Symbol: | FGF19 |
| Gene ID: | 9965 |
| Uniprot ID: | FGF19_HUMAN |
| Immunogen: | Recombinant Human FGF-19 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Phe27-Lys216) of human FGF-19 (Accession #NP_005108.1) fused with a 6×His tag at the C-terminus. |
| Immunogen Region: | Phe27-Lys216 |
| Immunogen Sequence: | FSDAGPHVHYGWGDPIRLRH LYTSGPHGLSSCFLRIRADG VVDCARGQSAHSLLEIKAVA LRTVAIKGVHSVRYLCMGAD GKMQGLLQYSEEDCAFEEEI RPDGYNVYRSEKHRLPVSLS SAKQRQLYKNRGFLPLSHFL PMLPMVPEEPEDLRGHLESD MFSSPLETDSMDPFGLVTGL EAVRSPSFEK |
Information sourced from Uniprot.org
